Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases
NCT02398526
·
clinicaltrials.gov ↗
COMPLETED
Status
363
Enrollment
INDUSTRY
Sponsor class
Conditions
Castration-Resistant Prostatic Cancer
Interventions
DRUG:
Radium-223 dichloride, (Xofigo, BAY88-8223)
Sponsor
Bayer